|
Gikakis, N; Khan, M M; Hiramatsu, Y et al. (1996) Effect of factor Xa inhibitors on thrombin formation and complement and neutrophil activation during in vitro extracorporeal circulation. Circulation 94:II341-6
|
|
Edmunds Jr, L H (1995) Hastings lecture. Breaking the blood-biomaterial barrier. ASAIO J 41:824-30
|
|
Wachtfogel, Y T; Hack, C E; Nuijens, J H et al. (1995) Selective kallikrein inhibitors alter human neutrophil elastase release during extracorporeal circulation. Am J Physiol 268:H1352-7
|
|
Edmunds Jr, L H (1995) Why cardiopulmonary bypass makes patients sick: strategies to control the blood-synthetic surface interface. Adv Card Surg 6:131-67
|
|
Colman, R W (1995) Hemostatic complications of cardiopulmonary bypass. Am J Hematol 48:267-72
|
|
Bernabei, A; Rao, A K; Niewiarowski, S et al. (1994) Recombinant desulfatohirudin as a substitute for heparin during cardiopulmonary bypass. J Thorac Cardiovasc Surg 108:381-2
|
|
Wachtfogel, Y T; Bischoff, R; Bauer, R et al. (1994) Alpha 1-antitrypsin Pittsburgh (Met358-->Arg) inhibits the contact pathway of intrinsic coagulation and alters the release of human neutrophil elastase during simulated extracorporeal circulation. Thromb Haemost 72:843-7
|
|
Wachtfogel, Y T; DeLa Cadena, R A; Kunapuli, S P et al. (1994) High molecular weight kininogen binds to Mac-1 on neutrophils by its heavy chain (domain 3) and its light chain (domain 5). J Biol Chem 269:19307-12
|
|
Edmunds Jr, L H (1994) Surface-bound heparin--panacea or peril? Ann Thorac Surg 58:285-6
|
|
Wachtfogel, Y T; Kucich, U; Hack, C E et al. (1993) Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion. J Thorac Cardiovasc Surg 106:1-9;discussion 9-10
|
Showing the most recent 10 out of 40 publications
